Proud to Support the Future of AI in Pharma 🤖💡 Last week at PharmaFWD Summit Series: The Innovative Marketer, we saw firsthand how Generative AI is moving from theory to real impact in pharma marketing. Normative was proud to sponsor the event and support the conversations shaping this rapidly evolving space. 🚀 From change management to compliance to proving ROI—real leaders are making AI work. Patrick Glinski moderated an incredible discussion with experts who have already implemented GenAI and shared what’s working (and what’s not). If you missed it, check out his key takeaways here: ⬇️ At Normative, we’ve spent over 15 years at the intersection of technology, design, and strategy—helping organizations make emerging tech actionable. If you’re looking to assess AI maturity, identify high-value use cases, or build an implementation plan, let’s talk. #PharmaFWD #GenAI #PharmaMarketing #AIInnovation #Normative
🔑 Takeaways from the genAI panel at the PharmaFWD Summit Series: The Innovative Marketer Last week, I had the opportunity to moderate a panel at PharmaFWD on the real-world adoption of Generative AI in pharma marketing. In events past, AI was just an exciting idea—now, it’s delivering real impact, as shared by our amazing panelists Vicky Lalumiere (Lundbeck), Jonathan Chiriboga (AstraZeneca), Erik Prieditis, P.Eng, MBA (Galderma), and prep partner Jeff Aikman (Novo Nordisk). Our panelists—leaders who have actually implemented GenAI—shared what’s working, what’s not, and what it really takes to bring AI into content operations. Here are a few of our panel takeaways: 1️⃣ What’s Possible? Depends on Who You Ask. Over the course of the event, we heard a number of companies speak very differently about what’s possible today. 🚀 Reality Check: Just because a team hasn’t done it yet doesn’t mean it’s not possible. As a panel, we agreed—embedding GenAI into production and MLR review is absolutely possible and already driving efficiency in our programs today. 2️⃣ You Won’t Have it All Figured Out—And That’s Okay A lot of teams hesitate because they feel they need a perfect AI strategy before moving forward. You won’t. The field is evolving too quickly to wait. 🗝️ Key Advice: Start small, focus on one high-impact use case, and iterate. AI adoption is about learning while doing—not waiting until everything is mapped out. 3️⃣ Don’t Get Hung Up on Quality—It’s Already Exceeding Expectations One of the biggest concerns with GenAI? “The quality isn’t there.” But we heard firsthand from panelists that AI-generated content is already meeting—and in some cases, exceeding—the standard set for employees and agencies. 📉 Biggest mistake? Using today’s quality concerns as an excuse to delay. AI is improving exponentially—if you wait for perfection, you’ll fall behind. 4️⃣ The Hardest Part? Getting People on Board 👯 GenAI in content operations isn’t just a technology shift—it’s an organizational shift. With so many stakeholders involved in content production, communicating and collaborating is what will make you successful. 💬 Manage that change: Everyone will be coming to the table with different preconceived hopes and fears. Following a change management framework to get your team on board will be a big help as you try to "Dream big, start small, and move quickly". 5️⃣ The #1 Advice from Every Panelist? JUST START. Every leader on stage agreed: The biggest risk isn’t moving too fast—it’s not moving at all. ✅ Experiment. ✅ Pilot real use cases. ✅ Build internal expertise. My teams at Normative and Compose Health Inc. see it every day - genAI isn’t just a “future opportunity” - it’s happening now. 💬 So what’s keeping your team from moving forward? Let’s discuss. 👇 #PharmaFWD #GenAI #PharmaMarketing #PharmaInnovation